Wakefield Asset Management’s Phibro Animal Health PAHC Stock Holding History

Wakefield Asset Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$963K	Buy	30,672 +340	+1%	+$14.3K	0.22%	139
2026 Q1	$1.68M	Buy	30,332 +368	+1%	+$17.5K	0.44%	64
2025 Q4	$1.12M	Sell	29,964 -9,364	-24%	-$380K	0.3%	103
2025 Q3	$1.59M	Sell	39,328 -12,842	-25%	-$424K	0.43%	73
2025 Q2	$1.33M	Sell	52,170 -380	-0.7%	-$8.29K	0.37%	82
2025 Q1	$1.12M	Buy	52,550 +3,980	+8%	+$89K	0.34%	91
2024 Q4	$1.02M	Buy	+48,570	New	+$1.12M	0.34%	96

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wakefield Asset Management's PAHC Position: Q2 2026 in Review

Wakefield Asset Management increased its Phibro Animal Health (PAHC) stake by 1.1% in Q2 2026, buying an estimated $14.3K and bringing the position to 30,672 shares worth $963K. The position accounts for 0.22% of the portfolio, ranked #139.

Wakefield Asset Management first reported a position in PAHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.68M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Wakefield Asset Management held 30,672 shares of Phibro Animal Health worth $963K as of Q2 2026.
Wakefield Asset Management bought 340 Phibro Animal Health shares in Q2 2026, an estimated $14.3K.
Phibro Animal Health made up 0.22% of Wakefield Asset Management's portfolio in Q2 2026, its #139 holding.
Wakefield Asset Management first reported a position in Phibro Animal Health in Q4 2024 and has held it in 7 quarters since.
Wakefield Asset Management's Phibro Animal Health position peaked at $1.68M in Q1 2026.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Wakefield Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.